摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-乙酰基-4-(4-氟苯基)-4-氧代丁酸乙酯 | 36967-50-7

中文名称
2-乙酰基-4-(4-氟苯基)-4-氧代丁酸乙酯
中文别名
——
英文名称
ethyl 2-acetyl-4-(4-fluorophenyl)-4-oxobutanoate
英文别名
2-Acetyl-4-(4-fluorophenyl)-4-oxobutyric acid ethyl ester
2-乙酰基-4-(4-氟苯基)-4-氧代丁酸乙酯化学式
CAS
36967-50-7
化学式
C14H15FO4
mdl
——
分子量
266.269
InChiKey
BPMXIGZWTQJKST-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    56.5-58 °C(Solv: ethyl ether (60-29-7))
  • 沸点:
    395.2±37.0 °C(Predicted)
  • 密度:
    1.182±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    19
  • 可旋转键数:
    7
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    60.4
  • 氢给体数:
    0
  • 氢受体数:
    5

反应信息

点击查看最新优质反应信息

文献信息

  • PYRROLO- AND THIAZOLO-PYRIDINE COMPOUNDS, AND METHODS OF USE THEREOF
    申请人:DENG Shaojiang
    公开号:US20080004309A1
    公开(公告)日:2008-01-03
    The present invention relates to novel compounds capable of modulating the stability and/or activity of hypoxia inducible factor (HIF).
    这项发明涉及一种能够调节缺氧诱导因子(HIF)稳定性和/或活性的新化合物。
  • Synthesis, Structure, and Antimalarial Activity of Some Enantiomerically Pure,<i>cis</i>-fused cyclopenteno-1,2,4-trioxanes
    作者:Charles W. Jefford、Shigeo Kohmoto、Danielle Jaggi、Géza Timári、Jean-Claude Rossier、Manyck Rudaz、Olivier Barbuzzi、David Gérard、Ulrich Burger、Philippe Kamalaprija、Jiri Mareda、Gérald Bernardinelli、Ignacio Manzanares、Craig J. Canfield、Suzanne L. Feck、Brain L. Robinson、Wallace Peters
    DOI:10.1002/hlca.19950780312
    日期:1995.5.10
    corresponding alcohols, and conversion to the (1S)-camphanates (Scheme 4), the structures of which are determined by X-ray analysis. The dynamic properties of ent-7 are investigated by NMR spectroscopy and PM3 calculations. Evidence for an easily accessible twist-boat conformation is obtained. The in vitro and in vivo antimalarial activities of 7, ent-7,8, and ent-8 as well as those of the racemic mixtures are
    制备了两对对映体纯的顺式稠合的环戊烯-1,2,4-三恶烷(7,ent - 7和8,ent - 8)(方案1-3)。它们的身份是通过对ent - 7和8,ent - 8进行烯丙基氢过氧化物的染料敏化光氧化,还原为相应的醇并转化为(1 S)-樟脑酸酯(方案4)而建立的(方案4)通过X射线分析确定。ent的动态属性-通过NMR光谱和PM3计算研究了图7。获得了易于操作的扭艇构型的证据。在体外和体内的抗疟疾活性7,耳鼻喉科- 7,8,和ENT - 8以及那些外消旋混合物的对被评价恶性疟原虫,柏氏疟原虫,和约氏疟原虫。在配置和活动之间未发现相关性。外消旋体和纯对映体具有相称的活性。通过在血红素分子表面上的三恶烷的旋舟构象异构体紧密对接,单电子转移到OOσ*轨道以及分裂到乙缩醛自由基,使对红细胞内寄生虫的作用方式合理化然后其不可逆地异构化为以C为中心的自由基,即最终的致死剂(方案5)。
  • Enantioselective Synthesis of Nitrogen–Nitrogen Biaryl Atropisomers via Copper-Catalyzed Friedel–Crafts Alkylation Reaction
    作者:Xiao-Mei Wang、Peng Zhang、Qi Xu、Chang-Qiu Guo、De-Bing Zhang、Chuan-Jun Lu、Ren-Rong Liu
    DOI:10.1021/jacs.1c07741
    日期:2021.9.22
    bioactive compounds. However, the atropisomerism arising from a restricted rotation around an N–N bond is largely overlooked. Here, we describe a method to access the first enantioselective synthesis of N–N biaryl atropisomers via a Cu-bisoxazoline-catalyzed Friedel–Crafts alkylation reaction. A wide range of axially chiral N–N bisazaheterocycle compounds were efficiently prepared in high yields with
    含有基序的氮-氮键在天然产物和生物活性化合物中无处不在。然而,由围绕 N-N 键的受限旋转引起的阻转异构在很大程度上被忽视了。在这里,我们描述了一种通过 Cu-双恶唑啉催化的 Friedel-Crafts 烷基化反应对 N-N 联芳基阻转异构体进行首次对映选择性合成的方法。通过去对称化和动力学拆分,以高产率高效制备了多种轴向手性 N-N 双氮杂杂环化合物,并具有优异的对映选择性。加热实验表明轴向手性双氮杂杂环产物具有高旋转势垒。
  • [EN] PROTON PUMP INHIBITORS<br/>[FR] INHIBITEURS DE POMPE A PROTONS
    申请人:TAKEDA PHARMACEUTICAL
    公开号:WO2006036024A1
    公开(公告)日:2006-04-06
    Proton pump inhibitors which have excellent proton pumping activity and which can be converted in vivo into proton pump inhibitors to exhibit antiulcer effect and so on, containing compounds represented by the general formula (I) or salts thereof or prodrugs of the same: (I) wherein X and Y are each independently a free valency or a spacer whose main chain has 1 to 20 carbon atoms; R1 is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group; R2, R3 and R4 are each independently hydrogen, an optionally substituted hydrocarbon group, optionally substituted thienyl, optionally substituted benzo[b]thienyl, optionally substituted furyl, optionally substituted pyridyl, optionally substituted pyrazolyl, optionally substituted pyrimidinyl, acyl, halogeno, cyano, or nitro; and R5 and R6 are each independently hydrogen or an optionally substituted hydrocarbon group.
    质子泵抑制剂具有优异的质子泵活性,可以在体内转化为质子泵抑制剂,表现出抗溃疡作用等,包含由通式(I)表示的化合物或其盐或类似物:(I)其中X和Y分别是自由价或其主链具有1至20个碳原子的间隔物;R1是可选择地取代的碳氢基团或可选择地取代的杂环基团;R2、R3和R4分别是氢、可选择地取代的碳氢基团、可选择地取代的噻吩基、可选择地取代的苯并[b]噻吩基、可选择地取代的呋喃基、可选择地取代的吡啶基、可选择地取代的吡唑基、可选择地取代的嘧啶基、酰基、卤素、氰基或硝基;R5和R6分别是氢或可选择地取代的碳氢基团。
  • Pyrrole Derivatives As Pharmaceutical Agents
    申请人:Canne Bannen Lynne
    公开号:US20080234270A1
    公开(公告)日:2008-09-25
    Compounds, compositions and methods for modulating the activity of receptors are provided. In particular compounds and compositions are provided for modulating the activity of receptors and for the treatment, prevention, or amelioration of one or more symptoms of disease or disorder directly or indirectly related to the activity of the receptors.
    提供了用于调节受体活性的化合物、组合物和方法。特别提供了用于调节受体活性的化合物和组合物,以及用于治疗、预防或改善与受体活性直接或间接相关的一种或多种疾病或紊乱的症状的方法。
查看更多